Received Jun 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | — |
Tinnitus; lost her ability to sleep; nerve pain; Headaches in the base of her skull; lost 15 pounds; Initial information received on 02-Jun-2026 regarding an unsolicited valid non-serious case received from a physician. This case involves a female patient of unknown age who experienced tinnitus, lost her ability to sleep, nerve pain, headaches in the base of her skull, and lost 15 pounds after receiving nvx-cov2705 (omicron jn. 1) adjuvanted vaccine (nuvaxovid). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. On an unspecified date, the patient received a dose (dose: unknown, frequency: unknown) of Nvx-Cov2705 (Omicron Jn.1) Adjuvanted Vaccine dispersion for injection (batch/lot number: asked but unknown; expiry date: unknown) (strength: unknown) via unknown route in an unknown administration site for COVID-19 prevention (COVID-19 immunisation). The patient experienced tinnitus, lost her ability to sleep (Insomnia), nerve pain (Neuralgia), headaches in the base of her skull (Headache) and lost 15 pounds (Weight decreased) (onset date: unknown, latency: unknown). Action taken: not applicable. Corrective treatment: Not reported. Event outcome: Tinnitus, lost her ability to sleep (Insomnia), nerve pain (Neuralgia), headaches in the base of her skull (Headache), and lost 15 pounds (Weight decreased) were not recovered/not resolved/ongoing.
Comments: NONE